Sinopharm Group Co. Ltd. (1099.HK)
Distributes medicines, medical devices, and healthcare products across China through hospitals, pharmacies, and clinics.
17.68+0.02%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-6.2%
The outlook
Sinopharm trades near the lower end of its 52-week range with analyst consensus tilted toward Buy. The average price target sits about 29% above the current level, though the stock's price trend against moving averages appears mixed. The valuation sits at a trailing P/E of 6.7, relatively modest for the sector.
What’s behind the score
Analyst consensusBuy — 1.8 avg of 14 analysts
Price trendMixed vs its moving averages
52-week range34% of the way from its 52-week low to high
Price targetAvg target +29% vs current price
Analyst price target
~12-month · 14 analysts22.74average target+28.6% vs now
Now 17.68
Low 17.18High 27.50
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$55.17B
52-wk high
22.34
52-wk low
15.28
50-day avg
16.96
200-day avg
19.42
Trailing P/E
6.7